Table 4 Psychotropic medications in the depression training and testing samples
From: Using heart rate profiles during sleep as a biomarker of depression
Training sample n (%) | Testing sample n (%) | |
|---|---|---|
Any psychotropic medication | 542 (81.6) | 69 (79.3) |
SSRI | 239 (36.0) | 28 (32.2) |
SNRI | 190 (28.6) | 19 (21.8) |
TCA | 39 (5.9) | 6 (6.9) |
NaSSA | 43 (6.5) | 2 (2.3) |
MAOI | 4 (0.6) | 1 (1.1) |
NRI/NARI | 5 (0.8) | 1 (1.1) |
SARI | 119 (17.9) | 25 (28.7) |
NDRI | 89 (13.4) | 12 (13.8) |
RIMA | 6 (0.9) | 1 (1.1) |
Other antidepressant | 0 (0.0) | 0 (0.0) |
Antipsychotic | 126 (19.0) | 0 (0.0) |
Mood stabilizer | 71 (10.7) | 8 (9.2) |
Lithium | 17 (2.6) | 3 (3.4) |
Melatonin agent | 15 (2.3) | 1 (1.1) |
Benzodiazepine | 96 (14.5) | 8 (9.2) |
Hypnotic/Sedative/Anxiolytic | 123 (18.5) | 2 (2.3) |
Stimulant | 38 (5.7) | 4 (4.6) |
Dopamine agonist | 1 (0.2) | 3 (3.4) |
NMDA receptor antagonist | 0 (0.0) | 1 (1.1) |
Acetylcholinesterase inhibitor | 1 (0.2) | 0 (0.0) |